The Medicine Hat branch of HIV Community Link is well known as the Medicine Hat Cares Centre. The primary focus of our Medicine Hat location is our harm reduction services that include a needle exchange program. In …
In the face of the fentanyl crisis in Alberta, naloxone is a new weapon to fight back. Naloxone is an opioid antagonist; this means that it blocks opioid receptors. Naloxone has no potential for misuse. Naloxone only works on opioids, meaning that if a person is not taking any opioids and gets injected with naloxone, nothing will happen.
At HIV Community Link we are committed to staying up-to-date on the latest and greatest information and trends affecting our work and the communities we serve. One way we do this is through our new series: What You Need to Know. The first four topics in this series are based on the most common and frequently asked questions we receive in-person, online, by phone, email and social media. Get in touch with all your questions – we’re the LINK!
At Shift, we don’t spend a whole lot of time talking about human trafficking.
In 2014, we provided ongoing support and case management to 125 registered program clients; only a handful of these individuals had experienced trafficking. In the 8 year history of Shift, people experiencing human trafficking and other forms of sexual exploitation have remained a small minority of the individuals we support.
New direct-acting Antivirals are changing chronic Hepatitis C treatment for the better. Hepatitis C (HCV) treatment has gone from a once exhausting 48 weeks duration to as a little as 8 weeks with a 95% sustained virologic response (SVR). SVR is defined as a viremia (the presence of viruses in the blood) 24 weeks after completion of antiviral therapy for chronic HCV infection (. In analyses of SVR durability, the incidence of late relapse is extremely low, less than 1%.
This year we are so excited that Kenneth Tupper, Ph.D., Dr. Carl Hart and Donald MacPherson will be joining us as plenary speakers and we can’t wait to see who else! The call for abstracts for anyone interested in presenting has gone out and anyone wishing to submit an abstract related to policy, practice or research should do so by February 9, 2015!! The more the better!!
Is a person who does not know their HIV status or who has never been tested pose a higher risk for HIV transmission due to their unknown or assumed HIV negative status than a person on TasP with controlled virus or on PreP and known HIV status? These are some of the questions being raised as a result of these new and emerging technologies.
We live in an increasingly global world and with that comes lots of travel, new experiences and health questions for those living with HIV and/or other chronic health conditions.
For some, a trip to the clinic for STI testing is as regular a part of their health routine as going to the doctor for a check-up. For others, it seems embarrassing, like they will …
YAH HOO! It is that time of year again. The cow folk are restless, the city is in anticipation with business and corporate sectors prepping the multitudes of pancake breakfasts and other Stampede celebration events …